| Literature DB >> 29777298 |
Christiane Pees1, Julian A Heno2, Gabriele Häusler3, Diana-Alexandra Ertl3, Talin Gulesserian2, Ina Michel-Behnke2.
Abstract
Turner syndrome (TS) is a common genetic disorder in females with high incidence of ascending aortic dilatation and even dissection occurring as early as in the second decade. Known risk factors (RF) are bicuspid aortic valves (BAV), coarctation of the aorta (CoA), and arterial hypertension. Since 10% of dissections occur in patients without RF, an intrinsic aortic wall abnormality has been postulated. This study aimed to investigate the elasticity of the ascending aorta as a surrogate marker of aortic wall texture. Forty-six pediatric patients with genetically proven TS were prospectively examined for the morphology of their aortic valve, and size and elasticity indices of the adjacent aorta. Cohorts of 46 female subjects with tricuspid aortic valves (TAV) and ten non-syndromic females with BAV were investigated as separate control groups. Comparison of healthy controls with TS patients revealed significantly deteriorated elasticity indices in those with TS. Furthermore, normalized aortic dimensions were greater in TS patients, but dilatations of the ascending aorta with z-score levels above two were restricted to those with BAV (14/46). Deteriorated elasticity indices were measured in TS patients, independent of aortic dilatation, BAV, and CoA, and were comparable to those of patients with isolated, non-syndromic BAVs. By measuring elasticity levels as a surrogate for aortic wall texture, we were able to gather evidence that TS presents with an intrinsic abnormality of the ascending aorta even in patients without concomitant BAV, CoA or dilatations as early as in childhood.Entities:
Keywords: Echocardiography; Genetics; Pediatrics; Vascular disease
Mesh:
Year: 2018 PMID: 29777298 PMCID: PMC6208677 DOI: 10.1007/s00380-018-1187-4
Source DB: PubMed Journal: Heart Vessels ISSN: 0910-8327 Impact factor: 2.037
Demographic data of the study population
| Control probands | Turner syndrome | ||
|---|---|---|---|
| Number of persons | 46 | 46 | |
| Age (years) [range] | 12.5 (5.7) [0–21] | 12.5 (5.7) [0–21] | 0.99 |
| Age distribution (years) | |||
| < 5 | 5 | 5 | |
| ≥ 5–10 | 11 | 11 | |
| ≥ 10–15 | 11 | 11 | |
| ≥ 15 | 19 | 19 | |
| Weight (kg) | 43.5 (19.7) | 39.5 (18.3) | 0.31 |
| Height (cm) | 146 (29) | 133 (27) |
|
| BSA (m2) | 1.32 (0.42) | 1.18 (0.39) | 0.09 |
| BMI (kg/m2) | 19.0 (4.3) | 20.6 (5.2) | 0.10 |
| BMI percentile | 46 (29) | 61 (28) |
|
| Systolic BP (mmhg) | 106 (13) | 114 (13) |
|
| Systolic BP percentile | 50 (28) | 75 (26) |
|
| Diastolic BP (mmhg) | 61 (9) | 68 (12) |
|
| Diastolic BP percentile | 48 (25) | 68 (27) |
|
| Pulse pressure | 45 (10) | 46 (10) | 0.89 |
Significant p values are highlighted in bold
Values are numbers or mean ± SD, significant p values are highlighted
BP blood pressure, BSA body surface area, BMI body mass index
Distribution of karyotypes in the Turner syndrome study population
| Karyotypes | Number of patients |
|---|---|
| Monosomie | |
| 45X | 25 |
| Mosaics | |
| 45X/46XX | 6 |
| 45X/47XX | 1 |
| 45X/46XY | 1 |
| Isochromosomes | |
| 45X/46Xi(Xq) | 4 |
| 45X/46Xi(Xq)/46X | 1 |
| 46Xi(Xq) | 3 |
| Deletions | |
| 45X/46Xdel(Xq) | 1 |
| 45X/46Xdel(Xp) | 1 |
| Ring chromosomes | |
| 45X/46Xr(X) | 2 |
| Isodicendric X | |
| 45X/46Xidic(Xp22) | 1 |
| Total | 46 |
Diameters, z-scores, and elasticity values of Turner syndrome patients and controls with and without BAV
| AV-D (mm) | AV | AoR-D (mm) | AoR z-score | STJ-D (mm) | STJ | AA-D (mm) | AA z-score | Stiffness | Distensibility (cm2 × dynes−1 × 10−6) | Distensibility (kPa−1 × 10−3) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Turner syndrome vs. controls | |||||||||||
| Turner syndrome (46) | 17.4 (4.2) | 0.33 (1.3) | 24.0 (6.0) | 0.70 (1.3) | 19.4 (5.1) | 0.53 (1.4) | 20.5 (6.1) | 0.54 (2.2) |
| 6.19 (2.58) | 49.8 (21.9) |
| Control TAV (46) | 17.3 (3.5) | 0.11 (1.0) | 23.6 (5.2) | − 0.09 (1.0) | 17.5 (4.4) | − 0.44 (0.8) | 18.5 (3.6) | − 1.01 (0.9) | 3.22 (0.85) | 8.23 (2.30) | 67.8 (19.9) |
| | 0.95 | 0.35 | 0.70 |
| 0.06 |
| 0.07 |
|
|
|
|
| Patients with BAV | |||||||||||
| TS BAV (14) | 17.4 (6.0) | 0.75 (1.7) | 24.7 (8.4) | 1.40 (1.5) | 20.6 (7.3) | 1.50 (1.6) | 24.1 (9.0) |
|
| 6.94 (2.94) | 55.8 (25.5) |
| Control BAV (10) | 17.3 (4.4) | 0.86 (1.2) | 21.7 (5.9) | 0.52 (1.1) | 19.5 (5.3) | 1.23 (1.2) | 23.3 (7.1) |
| 3.94 (1.46) | 7.28 (3.05) | 58.2 (25.2) |
| | 0.98 | 0.86 | 0.34 | 0.14 | 0.69 | 0.66 | 0.82 | 0.79 | 0.85 | 0.79 | 0.83 |
| Turner syndrome patients TAV vs. BAV | |||||||||||
| TS TAV (32) | 17.4 (3.1) | 0.15 (1.0) | 23.7 (4.7) | 0.40 (1.1) | 18.9 (3.8) | 0.11 (1.1) | 18.8 (3.2) | − 0.35 (1.3) |
|
|
|
| TS BAV (14) | 17.4 (6.0) | 0.75 (1.7) | 24.7 (8.4) | 1.40 (1.5) | 20.6 (7.3) | 1.50 (1.6) | 24.1 (9.0) |
|
| 6.94 (2.94) | 55.8 (25.5) |
| | 0.99 | 0.15 | 0.63 |
| 0.28 |
|
|
| 0.50 | 0.22 | 0.25 |
For elasticity parameters, corrected significance levels of 0.05, 0.025, and 0.0125 are assumed (Bonferroni–Holm)
AA Ascending aorta, AoR aortic root, AV aortic valve, BAV bicuspid aortic valve, D diameter, STJ sinutubular junction, TAV tricuspid aortic valve, TS Turner syndrome
Values are mean ± SD, pathological levels as well as significant p values are highlighted
Fig. 1Boxplot depiction of the stiffness index (a), the distensibility of the aortic root diameter (b), and the distensibility of the aortic root area (c) of 44 control probands vs. 26 Turner patients, each of them presenting without an aortic dilatation, a coarctation of the aorta or a bicuspid aortic valve